Detalles de la búsqueda
1.
Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study.
Lancet Oncol
; 22(10): 1468-1482, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34592180
2.
Assessment of immunogenicity from galcanezumab phase 3 trials in patients with episodic or chronic migraine.
Cephalalgia
; 40(9): 978-989, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32340471
3.
A first-in-human phase I trial of LY2780301, a dual p70 S6 kinase and Akt Inhibitor, in patients with advanced or metastatic cancer.
Invest New Drugs
; 33(3): 710-9, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25902900
4.
Prasugrel in children with sickle cell disease: pharmacokinetic and pharmacodynamic data from an open-label, adaptive-design, dose-ranging study.
J Pediatr Hematol Oncol
; 37(1): 1-9, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25493452
5.
Higher body weight patients on clopidogrel maintenance therapy have lower active metabolite concentrations, lower levels of platelet inhibition, and higher rates of poor responders than low body weight patients.
J Thromb Thrombolysis
; 38(2): 127-36, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24043374
6.
A Phase Ib/II Study of Ramucirumab in Combination with Emibetuzumab in Patients with Advanced Cancer.
Clin Cancer Res
; 25(17): 5202-5211, 2019 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31142504
7.
Population Pharmacokinetic and Exposure-Response Analyses of Prasugrel in Pediatric Patients with Sickle Cell Anemia.
Clin Pharmacokinet
; 57(2): 243-254, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28578536
8.
The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: a retrospective analysis of the FEATHER study.
Thromb Res
; 134(3): 552-7, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25022828
9.
Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery disease.
J Am Coll Cardiol
; 64(10): 1005-14, 2014 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25190236
10.
Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease.
Thromb Haemost
; 111(5): 943-50, 2014 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24402637
11.
Prasugrel 5 mg in the very elderly attenuates platelet inhibition but maintains noninferiority to prasugrel 10 mg in nonelderly patients: the GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients.
J Am Coll Cardiol
; 62(7): 577-83, 2013 Aug 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-23747759
Resultados
1 -
11
de 11
1
Próxima >
>>